Hamilton Lane Incorporated (HLNE) Price Target Lowered to $150 at UBS
On February 20, UBS lowered the firm’s price target on Hamilton Lane Incorporated (NASDAQ:HLNE) to $150 from $184 while maintaining a Buy rating, reflecting broader alternative...
Insider Monkey Blog
Credo Technology Group Holding Ltd (CRDO) Maintained at Overweight by JPMorgan
On February 26, JPMorgan analyst Joseph Cardoso stated that the recent selloff in Credo Technology Group Holding Ltd (NASDAQ:CRDO) appears excessive, maintaining an Overweight...
Scotiabank Cuts Essex Property Trust (ESS) Target, Says Multifamily Recovery Still Uneven
On March 4, Scotiabank analyst Nicholas Yulico lowered the firm’s price recommendation on Essex Property Trust, Inc. (NYSE:ESS) to $278 from $284.
Blackstone (BX) Coverage Reinstated by Barclays with $126 Price Target
On March 5, Barclays analyst Benjamin Budish reinstated coverage of Blackstone Inc. (NYSE:BX) with an Equal Weight rating.
Piper Sandler Lifts Chord Energy (CHRD) Target as War Risk Clouds Global Oil Supply
On March 5, Piper Sandler analyst Mark Lear raised the firm’s price recommendation on Chord Energy Corporation (NASDAQ:CHRD) to $158 from $151.
Scotiabank Cuts Mid-America Apartment Communities (MAA) Target, Sees Limited Near-Term Catalysts
On March 4, Scotiabank lowered its price recommendation on Mid-America Apartment Communities, Inc. (NYSE:MAA) to $140 from $142.
BofA Resumes Coverage on Ford (F), Sets $17 Target on Regulatory Tailwinds
On March 4, BofA reinstated coverage of Ford Motor Company (NYSE:F) with a Buy rating. The firm set a $17 price target on the stock.
Lincoln National (LNC) Price Target Cut to $46 at Morgan Stanley in Insurance Sector Update
On March 3, Morgan Stanley lowered its price recommendation on Lincoln National Corporation (NYSE:LNC) to $46 from $50. The firm reiterated an Overweight rating on the shares.
Barclays Lifts Extra Space Storage (EXR) Target as Self-Storage REIT Models Are Updated
On March 5, Barclays raised its price recommendation on Extra Space Storage Inc. (NYSE:EXR) to $170 from $164. It reiterated an Overweight rating on the shares.
VICI Properties (VICI) Price Target Cut to $34 at Baird Following Earnings Update
On March 2, Baird lowered its price recommendation on VICI Properties Inc. (NYSE:VICI) to $34 from $36. It kept an Outperform rating on the shares.
UPS Gets Price Target Increase from Jefferies on Infrastructure Advantage
On March 3, Jefferies raised the firm’s price recommendation on United Parcel Service, Inc. (NYSE:UPS) to $135 from $130. It reiterated a Buy rating on the shares.
Western Union Partners (WU) with Crossmint to Launch USD Stablecoin on Solana
On March 4, Crossmint, a platform that provides enterprise-grade stablecoin infrastructure, announced a partnership with The Western Union Company (NYSE:WU).
B&G Foods (BGS) Price Target Raised to $5 at Barclays After Green Giant Sale Move
On March 5, Barclays analyst Andrew Lazar raised the firm’s price recommendation on B&G Foods, Inc. (NYSE:BGS) to $5 from $4 and kept an Equal Weight rating on the shares.
KBW Raises Arbor Realty Trust (ABR) Price Target While Staying Bearish on Shares
On March 4, Keefe Bruyette analyst Jade Rahmani raised the firm’s price recommendation on Arbor Realty Trust, Inc. (NYSE:ABR) to $8 from $7.50.
RBC Lifts MFA Financial Target, Sees Potential for ROE Expansion
On March 5, RBC Capital raised its price recommendation on MFA Financial, Inc. (NYSE:MFA) to $11 from $10.
Cronos Group (CRON) Q4 2025 Earnings, Here’s a Snapshot
Cronos Group Inc. (NASDAQ:CRON) is one of the Low Risk Penny Stocks to Buy Now. On February 26, Cronos Group Inc. (NASDAQ:CRON) reported its fiscal Q4 2025 earnings.
Osisko Development (ODV) Resums Activities at Cariboo Gold Project
Osisko Development Corp. (NYSE:ODV) is one of the Low Risk Penny Stocks to Buy Now. On March 2, Osisko Development Corp.
Roth Capital Lowers PT on Playtika Holding (PLTK), Keeps a Hold Rating
Playtika Holding Corp. (NASDAQ:PLTK) is one of the Low Risk Penny Stocks to Buy Now. On March 5, Roth Capital lowered the firm’s price target on Playtika Holding Corp.
UBS Raises PT on Iovance Biotherapeutics (IOVA)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the Low Risk Penny Stocks to Buy Now.
BoFA Lowers PT on Recursion Pharmaceuticals (RXRX), Keeps a Hold Rating
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Low Risk Penny Stocks to Buy Now.
Baytex Energy (BTE) Releases FQ4 2025 Results, Enters 2026 as a Pure-Play Canadian Operator
Baytex Energy Corp. (NYSE:BTE) is one of the Low Risk Penny Stocks to Buy Now. On March 4, Baytex Energy Corp.
Cosan (CSAN)’s JV, Raizen Discussing $765 Million Injection
Cosan S.A. (NYSE:CSAN) is one of the Low Risk Penny Stocks to Buy Now. On March 4, Reuters reported that Cosan S.A.
Ultrapar Participações (UGP) Reports Q4 2025 Earnings, Here’s What You Need to Know
Ultrapar Participações S.A. (NYSE:UGP) is one of the Low Risk Penny Stocks to Buy Now. On March 4, Ultrapar Participações S.A.
Enel Chile (ENIC) Partners With Senapred to Improve Emergency Response Handling
Enel Chile S.A. (NYSE:ENIC) is one of the Low Risk Penny Stocks to Buy Now. On March 5, Enel Chile S.A.
Morgan Stanley Remains a Buy on Grab Holding (GRAB) Here’s Why
Grab Holdings Limited (NASDAQ:GRAB) is one of the Low Risk Penny Stocks to Buy Now.
Mohawk Industries (MHK) Falls as Housing Market Weakness Pressures Demand
Ariel Investments, an investment management company, released its “Ariel Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Core Laboratories (CLB) Gains on Sequential Revenue Growth and Solintec Acquisition
Ariel Investments, an investment management company, released its “Ariel Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Morgan Stanley Sees YPF Sociedad Anónima (YPF) Shale-Ready
On February 27, Morgan Stanley elevated the price target on YPF Sociedad Anónima (NYSE:YPF) to $47 from $45 and maintained an Equalweight rating.
Why Analysts Are Closely Watching Atlas Energy Solutions Inc. (AESI)
On February 26, Eddie Kim from Barclays lifted the price target on Atlas Energy Solutions Inc. (NYSE:AESI) to $8 from $7 and reiterated an Underweight rating.
Bristow Group Inc. (VTOL)’s 2026 Inflection Point: Is a Major Turnaround Coming?
Jason Bandel from Evercore ISI elevated the price target on Bristow Group Inc. (NYSE:VTOL) to $56 from $45 and reaffirmed an Outperform rating on February 27.
World Kinect Corporation (WKC) Faces Short-Term Risks but Shines in Dividend Growth
On March 3, Morgan Stanley cut the price target on World Kinect Corporation (NYSE:WKC) to $25, down from $27, and maintained an Underweight rating.
Why Morgan Stanley Is Bullish On Vista Energy, S.A.B. de C.V. (VIST)
On February 26, Morgan Stanley boosted the price target on Vista Energy, S.A.B. de C.V. (NYSE:VIST) to $74 from $73 and reiterated an Overweight rating.
BofA Sees Bright 2026/27 for Venture Global, Inc. (VG)
On March 3, BofA lifted the price target on Venture Global, Inc. (NYSE:VG) from $11 to $13 and reiterated a Buy rating, as reported by TheFly.
NextDecade Corporation (NEXT) Advances Financial and LNG Strategies, Shares Up 4%
After NextDecade Corporation (NASDAQ:NEXT) announced its fourth-quarter 2025 results on March 2, the stock rose around 4% by the close of March 3.
SM Energy Company (SM) Among Seven Undervalued Stocks Amid Rising Oil Risks
With rising tensions in the Middle East, analysts at KeyBanc Capital Markets remain positive on U.S. oil producers.
Why Antero Resources Corporation (AR) Remains in the Spotlight
On February 27, Gabriele Sorbara, an analyst at Siebert Williams Shank & Co., reiterated a Buy rating on Antero Resources Corporation (NYSE:AR) and set a price target of $48.
Is Expand Energy Corporation (EXE) The Best Affordable Energy Stock to Buy?
On February 23, Wells Fargo lifted the price target on Expand Energy Corporation (NASDAQ:EXE) to $123, up from $120, and reiterated an Equal Weight rating.
Gentex Corporation (GNTX) Drops After Earnings Miss Amid Lower-End Vehicle Production Mix
Ariel Investments, an investment management company, released its “Ariel Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Dentsply Sirona (XRAY) Added by Ariel Fund as Strategic Reset Targets Long-Term Growth
Ariel Investments, an investment management company, released its “Ariel Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Sphere Entertainment Co. (SPHR) Rallies on Strong Demand for The Wizard of Oz at Las Vegas Sphere
Ariel Investments, an investment management company, released its “Ariel Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
IDEAYA Biosciences, Inc. (IDYA) Enrolls First Patient in Phase 1 Trial of IDE034 Bispecific ADC
On February 25, 2026, IDEAYA Biosciences, Inc.
Stifel Lowers Its Price Target on Eos Energy Enterprises, Inc. (EOSE) to Maintains a Buy Rating
On February 27, 2026, Eos Energy Enterprises, Inc. (NASDAQ:EOSE) saw mixed analyst actions following recent results.
H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating
On February 27, 2026, H.C. Wainwright raised the firm's price target on CG Oncology, Inc. (NASDAQ:CGON) to $80 from $75 and maintained a Buy rating on the shares.
Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating
On February 25, 2026, Oppenheimer analyst Andreas Argyrides raised the firm’s price target on Tarsus Pharmaceuticals, Inc.
Truist Raises Its Price Target on BridgeBio Pharma, Inc. (BBIO) to $95 and Maintains a Buy Rating
On February 25, 2026, Truist analyst Danielle Brill raised the firm’s price target on BridgeBio Pharma, Inc.
H.C. Wainwright Lowered Its Price Target on SoundHound AI, Inc. (SOUN) to $20 and Maintains a Buy Rating
On March 2, 2026, H.C. Wainwright lowered the firm’s price target on SoundHound AI, Inc. (NASDAQ:SOUN) to $20 from $26 and maintained a Buy rating on the shares.
Truist Raises Its Price Target on CoreWeave, Inc. (CRWV) to $85 and Maintains a Hold Rating
On February 27, 2026, Truist analyst Arvind Ramnani raised the price target on CoreWeave, Inc. (NASDAQ:CRWV) to $85 from $84 and maintained a Hold rating following Q4 results.
Guggenheim Raises Its Price Target on Arcutis Biotherapeutics, Inc. (ARQT) to $35 and Maintains a Buy Rating
On February 27, 2026, Guggenheim raised its price target on Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) to $35 from $34 and maintained a Buy rating.
RBC Capital Lowers Its Price Target on Viridian Therapeutics, Inc. (VRDN) to $42 and Maintains an Outperform Rating
On February 27, 2026, RBC Capital lowered its price target on Viridian Therapeutics, Inc. (NASDAQ:VRDN) to $42 from $45 and maintained an Outperform rating.
H.C. Wainwright Raised Its Price Target on ImmunityBio, Inc. (IBRX) to $15 from $10 and Maintains a Buy Rating
On February 23, 2026, H.C. Wainwright raised its price target on ImmunityBio, Inc. (NASDAQ:IBRX) to $15 from $10 and maintained a Buy rating on the shares.
Hedge Fund Resource Center
